BSE filing, NSE: BPLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Bharat Parenterals Ltd: key numbers
- Share price
- ₹1,893.20
- Market cap
- ₹1,305 Cr
- Revenue (annual)
- ₹345.4 Cr
- Net profit (annual)
- ₹-8.19 Cr
- P/E (TTM)
- -84.7×Sector 46.1×
- Promoter holding
- 67.20%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bharat Parenterals Ltd
All →Bharat Parenterals Board Meeting Date
Bharat Parenterals will hold a board meeting on October 29, 2026 to consider unaudited standalone and consolidated results. Trading window has been closed since October 1, 2026.
Bharat Parenterals Annual General Meeting
Bharat Parenterals held an EGM via video conferencing on October 23, 2026. Members considered a preferential equity issue and Section 186 investment and guarantee limits.
Bharat Parenterals Business Update
Innoxel Lifesciences, a Bharat Parenterals subsidiary, began U.S. commercial supply of its first CMO product. This adds recurring manufacturing revenue to its existing licensing income.
Bharat Parenterals Preferential Issue
Bharat Parenterals filed a corrigendum to its EGM notice for a preferential issue exceeding ₹100 Crore. It adds a Crisil monitoring agency disclosure per BSE direction.
Bharat Parenterals Other Announcement
Bharat Parenterals Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as per regulatory requirements.
Bharat Parenterals Annual General Meeting
Bharat Parenterals Limited has issued a notice for an Extraordinary General Meeting (EGM) scheduled for October 23, 2026. Shareholders will consider preferential share issuance and investment approvals.
Other board meeting date announcements
All →GTV Engineering Board Meeting Date
GTV Engineering scheduled a Board Meeting for 5 November 2026 to approve unaudited Q2 and half-year financial results. No new information is disclosed beyond the meeting notice.
Elixir Capital Board Meeting Date
Elixir Capital Ltd notified BSE that its Board will meet on 6 Nov 2026 to consider Q2/H1FY27 results. No financial figures or decisions are reported yet.
Ecofinity Atomix Board Meeting Date
Ecofinity Atomix Ltd intimated BSE of a Board meeting on 7 November 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are stated.
Gorani Industries Board Meeting Date
Gorani Industries scheduled its Board meeting for 13 November 2026. It will consider the unaudited results for the September quarter and half-year.
Luxury Time Board Meeting Date
Luxury Time Ltd scheduled its board meeting for 3 Nov 2026 to consider H1 results, CFO replacement, and director remuneration. The filing is a prior intimation; no decisions have been made yet.
India Cements Capital Board Meeting Date
India Cements Capital Ltd scheduled its Audit Committee and Board meeting for 5 Nov 2026 to approve unaudited Q1/H1 FY27 results. Trading window remains closed until results publication on 7 Nov 2026.